A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel

Clinical Infectious Diseases

Volumn 54, Issue 7, 2012, Pages 938-945

  Goins, William P ^a   Edwards, Kathryn M ^b,c   Vnencak Jones, Cindy L ^d   Rock, Michael T ^b,c   Swift, Melanie ^b,c   Thayer, Valerie ^c   Schaffner, William ^e,f   Talbot, Thomas R ^e,f  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Division of General Internal Medicine   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d Division of Infectious Diseases ^*  (United States)

^e Division of Infectious Diseases   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL ASPIRATION; NOSE SMEAR; PERTUSSIS; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIBODIES, BACTERIAL; ANTITOXINS; AZITHROMYCIN; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH PERSONNEL; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NASOPHARYNX; OCCUPATIONAL EXPOSURE; POST-EXPOSURE PROPHYLAXIS; TREATMENT OUTCOME; WHOOPING COUGH; YOUNG ADULT;

EID: 84858134152     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir973     Document Type: Article

References (26)

1. CDC. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006; 55:1-37.
2. Deville JG, Cherry JD, Christenson PD, et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995; 21:639-42.
3. Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol 1999; 20:120-3.
4. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182:174-9. (Pubitemid 30497802)
5. Baggett HC, Duchin JS, Shelton W, et al. Two nosocomial pertussis outbreaks and their associated costs-King County, Washington, 2004. Infect Control Hosp Epidemiol 2007; 28:537-43. (Pubitemid 46814542)
6. Bassinet L, Matrat M, Njamkepo E, Aberrane S, Housset B, Guiso N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect Control Hosp Epidemiol 2004; 25:995-7. (Pubitemid 39551223)
7. Boulay BR, Murray CJ, Ptak J, Kirkland KB, Montero J, Talbot EA. An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol 2006; 27:92-5. (Pubitemid 46939761)
8. CDC. Outbreaks of pertussis associated with hospitals-Kentucky, Pennsylvania, and Oregon, 2003.MMWR Morb MortalWkly Rep 2005; 54:67-71.
9. Gehanno JF, Pestel-Caron M, Nouvellon M, Caillard JF. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect Control Hosp Epidemiol 1999; 20:549-52.
10. Kurt TL, Yeager AS, Guenette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972; 221:264-7.
11. Steketee RW, Wassilak SG, Adkins WN Jr, et al. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988; 157:434-40. (Pubitemid 18071439)
12. Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555-63. (Pubitemid 41434634)
13. CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines. MMWR Recomm Rep 2005; 54:1-16.
14. Sanofi Pasteur Inc. Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed Adacel package insert. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ UCM142764.pdf. Accessed 23 March 2010.
15. Hallander HO, Reizenstein E, Renemar B, Rasmuson G, Mardin L, Olin P. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J Clin Microbiol 1993; 31:50-2. (Pubitemid 23006577)
16. Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11:1045-53. (Pubitemid 39540842)
17. De Serres G, Boulianne N, Duval B. Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr Infect Dis J 1995; 14:969-75.
18. Halperin SA, Bortolussi R, Langley JM, Eastwood BJ, De Serres G. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection. Pediatrics 1999; 104:e42.
19. Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990; 9:1447-54.
20. Heininger U, Cherry JD, Stehr K. Serologic response and antibody-titer decay in adults with pertussis. Clin Infect Dis 2004; 38:591-4. (Pubitemid 38250973)
21. Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis 2004; 190:535-44.
22. Guthrie JL, Seah C, Brown S, Tang P, Jamieson F, Drews SJ. Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay. J Clin Microbiol 2008; 46:3798-9.
23. CDC. Outbreaks of respiratory illness mistakenly attributed to pertussis-New Hampshire, Massachusetts, and Tennessee, 2004-2006. MMWR Morb Mortal Wkly Rep 2007; 56:837-42.
24. Tatti KM, Wu KH, Tondella ML, et al. Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn Microbiol Infect Dis 2008; 61:264-72. (Pubitemid 351850241)
25. CDC. Pertussis (whooping cough). Available at: http://www.cdc.gov/ pertussis/surv-reporting.html. Accessed 15 December 2010.
26. CDC. Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-45.